The U.S. Food and Drug Administration approved the use of Yeztugo as an HIV prevention or “PrEP” medication in June 2025 as ...
The following article was originally published in Preventing Infection in Ambulatory Care, the quarterly e-publication from the Association for Professionals in Infection Control and Epidemiology ...
Introduction Maximising the impact of new and forthcoming long-acting injectable HIV pre-exposure prophylaxis (PrEP) products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results